Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial

International Journal of Cardiology

Volumn 167, Issue 4, 2013, Pages 1552-1559

  Kollum, M ^a   Heitzer, T ^a   Schmoor, C ^a   Brunner, M ^a   Witzenbichler, B ^a   Wiemer, M ^a   Hoffmann, R ^a   Gutleben, K J ^a   Schultheiss, H P ^a   Horstkotte, D ^a   Brachmann, J ^a   Meinertz, T ^a   Bode, Ch ^a   Zehender, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Angiography; Coronary artery disease (CAD); Drug eluting stents; Head to head study design; Intra individual comparisons; Vessel stenosis

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT LUMINAL LATE LOSS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MULTICENTER STUDY; NEOINTIMA; PACLITAXEL ELUTING STENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAFETY; SIROLIMUS ELUTING STENT;

ANGIOGRAPHY; CORONARY ARTERY DISEASE (CAD); DRUG ELUTING STENTS; HEAD TO HEAD STUDY DESIGN; INTRA-INDIVIDUAL COMPARISONS; VESSEL STENOSIS;

ADULT; AGED; AGED, 80 AND OVER; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVER VARIATION; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 84881474319     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.04.095     Document Type: Article

References (50)

1. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
2. G.W. Stone, S.G. Ellis, and L. Cannon Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial JAMA 294 2005 1215 1223
3. J.V. Tu, J. Bowen, and M. Chiu Effectiveness and safety of drug-eluting stents in Ontario N Engl J Med 357 2007 1393 1402
4. A. Kastrati, J. Mehilli, and J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
5. G.W. Stone, J.W. Moses, and S.G. Ellis Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents N Engl J Med 356 2007 998 1008
6. D. Frey, M. Billinger, and P. Meier Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model J Invasive Cardiol 20 2008 631 634
7. M. Joner, A.V. Finn, and A. Farb Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
8. M. Joner, G. Nakazawa, and A.V. Finn Endothelial cell recovery between comparator polymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342
9. D.I. Shin, K.B. Seung, and P.J. Kim Long-term coronary endothelial function after zotarolimus-eluting stent implantation. A 9 month comparison between zotarolimus-eluting and sirolimus-eluting stents Int Heart J 49 2008 639 652
10. P. Meier, R. Zbinden, and M. Togni Coronary collateral function long after drug-eluting stent implantation J Am Coll Cardiol 49 2007 15 20
11. G. Guagliumi, R. Virmani, and G. Musumeci Drug-eluting versus bare metal coronary stents: long-term human pathology. Findings from different coronary arteries in the same patient Ital Heart J 4 2003 713 720
12. J.R. Nebeker, R. Virmani, and C.L. Bennett Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project J Am Coll Cardiol 47 2006 175 181
13. B. Lagerqvist, S.K. James, U. Stenestrand, J. Lindback, T. Nilsson, and L. Wallentin Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden N Engl J Med 356 2007 1009 1019
14. S. Windecker, and B. Meier Late coronary stent thrombosis Circulation 116 2007 1952 1965
15. A.V. Finn, M. Joner, and G. Nakazawa Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441
16. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
17. M.C. Morice, A. Colombo, and B. Meier Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial JAMA 295 2006 895 904
18. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662
19. A. Kastrati, J. Mehilli, and B.N. von Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial JAMA 293 2005 165 171
20. J.J. Goy, J.C. Stauffer, M. Siegenthaler, A. Benoit, and C. Seydoux A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology: the TAXi trial J Am Coll Cardiol 45 2005 308 311
21. A. Dibra, A. Kastrati, and J. Mehilli Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients N Engl J Med 353 2005 663 670
22. J. Mehilli, A. Dibra, A. Kastrati, J. Pache, J. Dirschinger, and A. Schomig Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels Eur Heart J 27 2006 260 266
23. P.W. Serruys, J.P. de, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group N Engl J Med 331 1994 489 495
24. D.L. Fischman, M.B. Leon, and D.S. Baim A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators N Engl J Med 331 1994 496 501
25. C.M. Gibson, R.E. Kuntz, M. Nobuyoshi, B. Rosner, and D.S. Baim Lesion-to-lesion independence of restenosis after treatment by conventional angioplasty, stenting, or directional atherectomy. Validation of lesion-based restenosis analysis Circulation 87 1993 1123 1129
26. B.J. Rensing, W.R. Hermans, and J. Vos Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group Circulation 88 1993 975 985
27. D.P. Foley, R. Melkert, and P.W. Serruys Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty Circulation 90 1994 1239 1251
28. D.P. Faxon Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MARCATOR) Study Group J Am Coll Cardiol 25 1995 362 369
29. A. Kastrati, A. Schomig, S. Elezi, H. Schuhlen, M. Wilhelm, and J. Dirschinger Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions Circulation 97 1998 2396 2401
30. M.I. Hamilos, M. Ostojic, and B. Beleslin Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion J Am Coll Cardiol 51 2008 2123 2129
31. S.H. Hur, J. Ako, and Y. Shimada Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study J Invasive Cardiol 20 2008 411 416
32. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, J.W. Jukema, and M.V. Huisman Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis Am Heart J 154 2007 221 231
33. D.W. Park, Y.H. Kim, and S.C. Yun Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial J Am Coll Cardiol 56 2010 1187 1195
34. L. Campeau The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later Can J Cardiol 18 2002 371 379
35. E. Braunwald Unstable angina. A classification Circulation 80 1989 410 414
36. A. Colombo, J. Drzewiecki, and A. Banning Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
37. R. Piccolo, S. Cassese, G. Galasso, R.R. De, C. D'Anna, and F. Piscione Long-term safety and efficacy of drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized trials Atherosclerosis 217 2011 149 157
38. J. Schofer, M. Schluter, and A.H. Gershlick Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
39. G. Weisz, M.B. Leon, and D.R. Holmes Jr. Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial J Am Coll Cardiol 47 2006 1350 1355
40. K. Tiroch, W. Koch, J. Mehilli, C. Bottiger, A. Schomig, and A. Kastrati P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents Cardiology 112 2009 263 269
41. A. Richardson, and S.B. Kaye Drug resistance in ovarian cancer: the emerging importance of gene transcription and spatio-temporal regulation of resistance Drug Resist Updat 8 2005 311 321
42. S. Huang, M.A. Bjornsti, and P.J. Houghton Rapamycins: mechanism of action and cellular resistance Cancer Biol Ther 2 2003 222 232
43. J. Cosgrave, G. Melzi, and S. Corbett Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent Am Heart J 153 2007 354 359
44. F. Tomai, B. Reimers, and L.L. De Head-to-head comparison of sirolimus- and paclitaxel-eluting stent in the same diabetic patient with multiple coronary artery lesions: a prospective, randomized, multicenter study Diabetes Care 31 2008 15 19
45. M. Billinger, J. Beutler, and K.R. Taghetchian Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients Eur Heart J 29 2008 718 725
46. J.S. Kim, B.H. Lee, and Y.G. Ko Comparison of sirolimus-eluting stent and paclitaxel-eluting stent for long-term cardiac adverse events in diabetic patients: the Korean Multicenter Angioplasty Team (KOMATE) Registry Catheter Cardiovasc Interv 72 2008 601 607
47. C. Chan, R. Zambahari, and U. Kaul A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: the DECODE study Catheter Cardiovasc Interv 72 2008 591 600
48. L.O. Jensen, M. Maeng, and P. Thayssen Neointimal hyperplasia after sirolimus-eluting and paclitaxel-eluting stent implantation in diabetic patients: the Randomized Diabetes and Drug-Eluting Stent (DiabeDES) Intravascular Ultrasound Trial Eur Heart J 29 2008 2733 2741
49. S.W. Lee, S.W. Park, and Y.H. Kim A randomized comparison of sirolimus- versus paclitaxel-eluting stent implantation in patients with diabetes mellitus J Am Coll Cardiol 52 2008 727 733
50. A.N. Buch, A. Javaid, and D.H. Steinberg Outcomes after sirolimus- and paclitaxel-eluting stent implantation in patients with insulin-treated diabetes mellitus Am J Cardiol 101 2008 1253 1258